breast cancer resistance protein

You have access
Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
Nicolas Tournier and Oliver Langer

Journal of Nuclear Medicine May 1, 2025, 66 (5) 676-680; DOI: https://doi.org/10.2967/jnumed.124.269322
You have access
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, Cécile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger and Oliver Langer

Journal of Nuclear Medicine April 1, 2019, 60 (4) 486-491; DOI: https://doi.org/10.2967/jnumed.118.216432
You have access
Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, Ourkia-Badia Helal, Irène Buvat, Michael Soussan, Fabien Caillé and Oliver Langer

Journal of Nuclear Medicine January 1, 2017, 58 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.116.178665
You have access
Whole-Body Distribution and Radiation Dosimetry of ¹¹C-Elacridar and ¹¹C-Tariquidar in Humans
Martin Bauer, Matthias Blaickner, Cécile Philippe, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger and Oliver Langer

Journal of Nuclear Medicine August 1, 2016, 57 (8) 1265-1268; DOI: https://doi.org/10.2967/jnumed.116.175182
You have access
Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide
Géraldine Pottier, Solène Marie, Sébastien Goutal, Sylvain Auvity, Marie-Anne Peyronneau, Simon Stute, Raphaël Boisgard, Frédéric Dollé, Irène Buvat, Fabien Caillé and Nicolas Tournier

Journal of Nuclear Medicine February 1, 2016, 57 (2) 309-314; DOI: https://doi.org/10.2967/jnumed.115.164350
You have access
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of ¹¹C-Erlotinib
Alexander Traxl, Thomas Wanek, Severin Mairinger, Johann Stanek, Thomas Filip, Michael Sauberer, Markus Müller, Claudia Kuntner and Oliver Langer

Journal of Nuclear Medicine December 1, 2015, 56 (12) 1930-1936; DOI: https://doi.org/10.2967/jnumed.115.161273
You have access
Interaction of ¹¹C-Tariquidar and ¹¹C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Markus Zeitlinger, Johann Stanek, Cécile Philippe, Wolfgang Wadsak, Markus Mitterhauser, Walter Jäger, Helmuth Haslacher, Markus Müller and Oliver Langer

Journal of Nuclear Medicine August 1, 2013, 54 (8) 1181-1187; DOI: https://doi.org/10.2967/jnumed.112.118232
You have access
Evaluation of Breast Cancer Resistance Protein Function in Hepatobiliary and Renal Excretion Using PET with ¹¹C-SC-62807
Tadayuki Takashima, Chunyong Wu, Misato Takashima-Hirano, Yumiko Katayama, Yasuhiro Wada, Masaaki Suzuki, Hiroyuki Kusuhara, Yuichi Sugiyama and Yasuyoshi Watanabe

Journal of Nuclear Medicine February 1, 2013, 54 (2) 267-276; DOI: https://doi.org/10.2967/jnumed.112.110254

Main menu

User menu

Search

breast cancer resistance protein